Journal article
Mast cell‐derived samd14 is a novel regulator of the human prostate tumor microenvironment
LKH Teng, BA Pereira, S Keerthikumar, C Huang, B Niranjan, SN Lee, M Richards, RB Schittenhelm, L Furic, DL Goode, MG Lawrence, RA Taylor, SJ Ellem, GP Risbridger, NL Lister
Cancers | MDPI | Published : 2021
Open access
Abstract
Mast cells (MCs) are important cellular components of the tumor microenvironment and are significantly associated with poor patient outcomes in prostate cancer and other solid cancers. The promotion of tumor progression partly involves heterotypic interactions between MCs and cancer‐associated fibroblasts (CAFs), which combine to potentiate a pro‐tumor extracellular matrix and promote epithelial cell invasion and migration. Thus far, the interactions between MCs and CAFs remain poorly understood. To identify molecular changes that may alter resident MC function in the prostate tumor microenvironment, we profiled the transcriptome of human prostate MCs isolated from patient‐matched non‐tumor ..
View full abstractGrants
Awarded by Victorian Cancer Agency
Funding Acknowledgements
This work was supported by the National Health and Medical Research Council, Australia (fellowship to G.P.R. 1102752), the Department of Health and Human Services acting through the Victorian Cancer Agency (fellowships to L.F. MCRF16007, M.G.L. MCRF18017, R.A.T. MCRF15023, D.L.G MCRF17005, CAPTIV Program), the Peter MacCallum Cancer Foundation (D.L.G.), the EJ Whitten Foundation, the Peter and Lyndy White Foundation, and TissuPath Pathology.